drugset / Trial / NCT02099695

Evaluate the Efficacy of Oxybutynin Chloride in Patients With Primary Hyperhidrosis

NCT02099695

RandomizedParallel-groupDouble-blindTreatment

Summary

Treatment of primary hyperhidrosis through a comparative study between oxybutynin hydrochloride and placebo. Hydrochloride may decrease the symptoms of hyperhidrosis improving the subject's quality of life.

Timeline

Start
2015-12
Primary completion
2016-01
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxybutynin Small molecule 5 mg
Comparator Oxybutynin Small molecule 10 mg